ARTHUR TZIANABOS Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ARTHUR TZIANABOS.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ARTHUR TZIANABOS. ARTHUR TZIANABOS is a Director in BIND Therapeutics, Inc ($BIND) and a Chief Scientific Officer in OvaScience, Inc. ($OVAS) and a President and CSO in OvaScience, Inc. ($OVAS) and a Director in Stoke Therapeutics, Inc. ($STOK) and a President & CEO in Homology Medicines, Inc. ($FIXX).

Address: C/O OVASCIENCE, INC., 215 FIRST STREET, SUITE 240 CAMBRIDGE 02142 MA

Companies in which ARTHUR TZIANABOS is an Insider

DNIB UNWIND, INC.

Trading Symbol: BIND
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARTHUR TZIANABOS: Director
Holdings: 15,000 shares
Latest Transaction: Aug 30 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Homology Medicines, Inc.

Trading Symbol: FIXX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARTHUR TZIANABOS: President & CEO
Holdings: 77,505 shares
Latest Transaction: Feb 09 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Millendo Therapeutics, Inc.

Trading Symbol: OVAS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARTHUR TZIANABOS: President and CSO, Chief Scientific Officer
Holdings: 25,400 shares
Current Value: $37,846
Latest Transaction: Dec 07 2015
$OVAS Market Capitalization: $55.19M
$OVAS Previous Close: $1.49

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Stoke Therapeutics, Inc.

Trading Symbol: STOK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARTHUR TZIANABOS: Director
Holdings: 10,000 shares
Latest Transaction: Feb 23 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of ARTHUR TZIANABOS

Sentiment: All, BIND, FIXX, OVAS, STOK

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 23 2021STOKStoke Therapeutics ...TZIANABOS ARTHURDirectorOption ExerciseM2.1910,00021,90013,447
Feb 23 2021STOKStoke Therapeutics ...TZIANABOS ARTHURDirectorSellS60.6710,000606,652010 K to 0 (-100.00 %)
Feb 23 2021STOKStoke Therapeutics ...TZIANABOS ARTHURDirectorBuyM2.1910,00021,90010,0000 to 10 K
Feb 09 2021FIXXHomology Medicines ...TZIANABOS ARTHURPresident & CEOOption ExerciseA0.0042,000042,000
Feb 09 2021FIXXHomology Medicines ...TZIANABOS ARTHURPresident & CEOOption ExerciseA13.78254,0003,500,120254,000
Jun 05 2020STOKStoke Therapeutics ...TZIANABOS ARTHURDirectorOption ExerciseA26.5314,777392,03414,777
Feb 05 2020FIXXHomology Medicines ...TZIANABOS ARTHURPresident & CEOSellS16.1612,500202,02177,50590 K to 77.5 K (-13.89 %)

View all ARTHUR TZIANABOS insider transactions.